chloroquine has been researched along with puromycin in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (30.77) | 18.7374 |
| 1990's | 4 (10.26) | 18.2507 |
| 2000's | 4 (10.26) | 29.6817 |
| 2010's | 16 (41.03) | 24.3611 |
| 2020's | 3 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
| Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
| Avery, VM; Sykes, ML | 1 |
| Avery, VM; Baell, JB; Bergström, CA; Charman, SA; Ferrins, L; Gazdik, M; Jones, AJ; Kaiser, M; Rahmani, R; Ryan, E; Sykes, ML; Varghese, S; White, KL | 1 |
| Akoto, M; Avery, VM; Duffy, S; Hagen, TJ; Helgren, TR; Igbinoba, O; Lee, P; Sciotti, RJ | 1 |
| Capela, R; Lopes, F; Magalhães, J; Miranda, D; Moreira, R; O'Neill, PM; Oliveira, R; Perry, MJ | 1 |
| Avery, V; Derese, S; Deyou, T; Duffy, S; Erdélyi, M; Fitzpatrick, PA; Gruhonjic, A; Gumula, I; Heydenreich, M; Holleran, J; Landberg, G; Mumo, M; Pang, F; Rissanen, K; Yenesew, A | 1 |
| Avery, VM; Duffy, S; Khalaf, AI; Scott, FJ; Suckling, CJ | 1 |
| Avery, VM; Carroll, AR; Duffy, S; Senadeera, SPD | 1 |
| Avery, VM; Davis, RA; Duffy, S; Kumar, R | 1 |
| Avery, VM; Carroll, AR; Duffy, S; Robertson, LP; Wang, D; Wang, Y | 1 |
| Avery, VM; Carroll, AR; Davis, RA; Duffy, S; Kumar, R | 1 |
| Avery, VM; Carroll, AR; Duffy, S; Lucantoni, L; Senadeera, SPD | 1 |
| Avery, VM; Butler, GS; Drinkwater, N; Duffy, S; Grin, PM; Kassiou, M; Lucantoni, L; Malcolm, TR; McGowan, S; Overall, CM; Scammells, PJ; Vinh, NB | 1 |
| Avery, VM; Baell, JB; Ban, K; Beveridge, JG; Blundell, S; Charman, SA; Chavchich, M; Chiu, FCK; Creek, D; Cuellar, ME; Dahlin, JL; Diab, S; Dingjan, T; Duffy, S; Edstein, MD; Ellis, K; Fletcher, S; Harjani, JR; Huang, F; Lucantoni, L; Marfurt, J; Noviyanti, R; Price, RN; Ralph, SA; Shi, DH; Strasser, JM; Teguh, S; Walters, MA; Wirjanata, G; Xue, L | 1 |
| Avery, VM; Carroll, AR; Duffy, S; Lucantoni, L; Robertson, LP | 1 |
| Avery, VM; Duffy, S; Erdélyi, M; Lindblad, S; Maeda, G; Munissi, JJE; Nyandoro, SS; Pelletier, J | 1 |
| Avery, VM; Carroll, AR; Holland, DC; Kennedy, EK; Kleks, G | 1 |
| Avery, VM; Challis, MP; Creek, DJ; De Paoli, A; Devine, SM; Kigotho, JK; MacRaild, CA; Norton, RS; Scammells, PJ; Siddiqui, G | 1 |
| Artemenko, NK; Freidlin, IS; Lyzlova, SN; Nersesova, LS; Petrova, TA | 1 |
| Homma, S; Oppenheim, RW; Prevette, D; Tytell, M | 1 |
| Ekong, RM; Kirby, GC; Patel, G; Phillipson, JD; Warhurst, DC | 1 |
| Knutson, VP; Lane, MD; Ronnett, GV | 1 |
| Baggaley, VC; Homewood, CA; Warhurst, DC | 1 |
| Hussain Qadri, SM; Williams, RP | 1 |
| Gonasun, LM; Potts, AM | 1 |
| Aikawa, M; Cook, RT; Fournier, MJ; Rock, RC | 1 |
| Robinson, BL; Warhurst, DC | 1 |
| Doss, M | 1 |
| Brostoff, J; Krejci, J; Pick, E; Turk, JL | 1 |
| Gollapudi, SV; Kern, M; Ramanadham, M | 1 |
| Jørgensen, J | 1 |
| Kovács, AL; Seglen, PO | 1 |
| Bradley, C; Henriquez, DA; Pance, A; Perez, N | 1 |
| Chambon, Y; Djehiche, B; Segalen, J | 1 |
| Früh, K; Gruhler, A; Peterson, PA | 1 |
| Cai, GZ; Chen, YF; Fitch, CD; Ryerse, JS | 1 |
| Callegari, EA; Chien, J; Drappeau, DD; Eyster, KM; Gamarra-Luques, CD; Goyeneche, AA; Hapon, MB; Knapp, JR; Pan, B; Srinivasan, R; Telleria, CM; Terpstra, EJ; Wang, X; Zhang, L | 1 |
2 review(s) available for chloroquine and puromycin
| Article | Year |
|---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
From hybrid compounds to targeted drug delivery in antimalarial therapy.
Topics: Aminoquinolines; Animals; Antimalarials; Drug Delivery Systems; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Targeted Therapy; Peroxides; Plasmodium; Polypharmacology | 2015 |
37 other study(ies) available for chloroquine and puromycin
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
Topics: Animals; Benzamides; Cell Line; HEK293 Cells; Humans; Microsomes, Liver; Myoblasts; Pyridines; Rats; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense | 2014 |
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
Topics: Antimalarials; Humans; Malaria; Models, Molecular; Molecular Structure; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quercetin; Stereoisomerism | 2015 |
Rotenoids, Flavonoids, and Chalcones from the Root Bark of Millettia usaramensis.
Topics: Antimalarials; Chalcones; Chloroquine; Crystallography, X-Ray; Flavanones; Flavonoids; HEK293 Cells; Humans; Millettia; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Plant Extracts; Plasmodium falciparum | 2015 |
Selective anti-malarial minor groove binders.
Topics: Antimalarials; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2016 |
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
Topics: Antimalarials; Australia; Cell Survival; Chloroquine; Drug Resistance; Flowers; HEK293 Cells; Humans; Ketones; Magnetic Resonance Spectroscopy; Molecular Conformation; Myrtaceae; Plant Extracts; Plasmodium falciparum; Sesquiterpenes | 2017 |
Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid.
Topics: Amides; Antimalarials; Australia; Biological Products; Cell Survival; Diterpenes; Dose-Response Relationship, Drug; Eremophila Plant; HEK293 Cells; Humans; Molecular Structure; Plant Extracts; Plasmodium falciparum; Structure-Activity Relationship | 2017 |
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
Topics: Antimalarials; Australia; Biological Products; Indole Alkaloids; Magnetic Resonance Spectroscopy; Plant Extracts; Plant Leaves; Plasmodium falciparum; Rutaceae; Trees | 2017 |
Microthecaline A, a Quinoline Serrulatane Alkaloid from the Roots of the Australian Desert Plant Eremophila microtheca.
Topics: Alkaloids; Antimalarials; Australia; Biological Products; Eremophila Plant; Plant Extracts; Plant Roots; Plasmodium falciparum; Quinolines | 2018 |
Antiplasmodial β-Triketone-Flavanone Hybrids from the Flowers of the Australian Tree Corymbia torelliana.
Topics: Antimalarials; Flavanones; Flowers; HEK293 Cells; Humans; Ketones; Magnetic Resonance Spectroscopy; Molecular Structure; Myrtaceae; Plant Extracts; Trees | 2018 |
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
Topics: Aminopeptidases; Antimalarials; Binding Sites; Catalytic Domain; Cell Survival; Drug Resistance; HEK293 Cells; Humans; Hydroxamic Acids; Molecular Docking Simulation; Plasmodium; Protease Inhibitors; Protozoan Proteins; Structure-Activity Relationship | 2019 |
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Plasmodium; Species Specificity; Structure-Activity Relationship; Triazines | 2019 |
Acrotrione: An Oxidized Xanthene from the Roots of Acronychia pubescens.
Topics: Oxidation-Reduction; Plant Roots; Rutaceae; Xanthenes | 2019 |
A Meroisoprenoid, Heptenolides, and
Topics: Annonaceae; Antimalarials; Flavanones; Flavonoids; HEK293 Cells; Humans; Molecular Structure; Plant Extracts; Plant Leaves; Plasmodium berghei; Plasmodium falciparum | 2020 |
Antiplasmodial Alkaloids from the Australian Bryozoan
Topics: Animals; Antimalarials; Australia; HEK293 Cells; Humans; Plasmodium falciparum; Spectrum Analysis | 2020 |
Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
Topics: Antimalarials; Benzimidazoles; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
[Changes in the functional activity of macrophages, their morphology and metabolism under the influence of several biologically active substances].
Topics: Ascorbic Acid; Carbon Radioisotopes; Cathepsins; Chloramphenicol; Chloroquine; Creatine Kinase; Culture Techniques; Cycloheximide; Dactinomycin; Lipopolysaccharides; Lysine; Macrophages; Orotic Acid; Peritoneum; Phagocytosis; Protein Biosynthesis; Puromycin; Rifampin; RNA; Tetracycline; Uridine | 1975 |
Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes.
Topics: Animals; Cell Survival; Chick Embryo; Chloroquine; Curare; Cycloheximide; Dactinomycin; Ganglia, Spinal; Gene Expression; Genotype; Leupeptins; Microscopy, Electron; Motor Neurons; Protein Biosynthesis; Puromycin; RNA; Spinal Cord | 1990 |
Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis.
Topics: Animals; Anisomycin; Chloroquine; Plasmodium falciparum; Protein Synthesis Inhibitors; Puromycin; Pyrrolidines; Structure-Activity Relationship | 1990 |
The effects of cycloheximide and chloroquine on insulin receptor metabolism. Differential effects on receptor recycling and inactivation and insulin degradation.
Topics: Animals; Cell Line; Chloroquine; Cycloheximide; Dactinomycin; Fibroblasts; Insulin; Kinetics; Mice; Pactamycin; Protein Biosynthesis; Puromycin; Receptor, Insulin; RNA, Messenger | 1985 |
The chemotherapy of rodent malaria. XX. Autophagic vacuole formation in Plasmodium berghei in vitro.
Topics: Animals; Anti-Bacterial Agents; Chloroquine; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Erythrocytes; In Vitro Techniques; Inclusion Bodies; Malaria; Mice; Pigments, Biological; Plasmodium berghei; Protein Biosynthesis; Puromycin; Time Factors; Vacuoles | 1974 |
Biosynthesis of the tripyrrole bacterial pigment, prodigiosin, by nonproliferating cells of Serratia marcescens.
Topics: Amino Acids; Anti-Bacterial Agents; Carbon Isotopes; Cell Count; Chloramphenicol; Chloroquine; Cycloheximide; Dactinomycin; Fluorouracil; Kinetics; Mitomycins; Pigments, Biological; Prodigiosin; Proteins; Puromycin; Pyrroles; Serratia marcescens; Streptomycin; Temperature; Tryptophan | 1972 |
In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine.
Topics: Animals; Carbon Radioisotopes; Cattle; Chloroquine; Cycloheximide; Epithelium; Eye Proteins; Hydroxychloroquine; In Vitro Techniques; Leucine; Lysine; Phenylalanine; Puromycin; Quinine; Retina; Tissue Extracts | 1974 |
Ribosomes of the malarial parasite, Plasmodium knowlesi. I. Isolation, activity and sedimentation velocity.
Topics: Amino Acids; Animals; Bile Acids and Salts; Biological Evolution; Carbon Isotopes; Cell Fractionation; Chloramphenicol; Chloroquine; Cycloheximide; Dialysis; Filtration; Haplorhini; Kinetics; Macaca; Magnesium; Microscopy, Electron; Plasmodium; Protein Biosynthesis; Puromycin; Ribosomes; Streptomycin; Ultracentrifugation | 1971 |
Cytotoxic agents and haemozoin pigment in malaria parasites (Plasmodium berghei).
Topics: Animals; Antineoplastic Agents; Azaserine; Chloramphenicol; Chloroquine; Cycloheximide; Cytoplasm; Dactinomycin; Injections, Intraperitoneal; Malaria; Male; Mercaptopurine; Mice; Mitomycins; Nucleic Acids; Pigments, Biological; Plasmodium; Protein Biosynthesis; Puromycin; Streptomycin; Tetracycline; Uracil | 1971 |
[Porphyrin synthesis in liver cell culture under the influence of drugs and steroids].
Topics: 17-Ketosteroids; Androstanes; Animals; Anti-Bacterial Agents; Barbiturates; Chick Embryo; Chloramphenicol; Chloroquine; Culture Techniques; Dactinomycin; Glutethimide; Griseofulvin; Hypnotics and Sedatives; Liver; Meprobamate; Mitomycins; Oxyphenbutazone; Porphyrins; Pregnanediol; Pregnanes; Pregnanetriol; Puromycin; Pyridines; Spectrophotometry; Stimulation, Chemical; Sulfamoxole | 1969 |
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors.
Topics: Animals; Antigens; Ascitic Fluid; Cell Migration Inhibition; Cells, Cultured; Chloramphenicol; Chloroquine; Chlorphenesin; Chromatography, Gel; Concanavalin A; Dactinomycin; Freund's Adjuvant; Guinea Pigs; Hemadsorption; Hydrocortisone; Immunization; Immunoelectrophoresis; Immunosuppression Therapy; Inflammation; Lectins; Lymph Nodes; Lymphocytes; Macrophages; Male; Mitosis; Puromycin; Skin Tests; Thymus Gland | 1970 |
Anti-immunoglobulin-induced proliferation of B cells. Parallelism in the inhibition by chloroquine, monensin and immunoglobulin.
Topics: Animals; Antibodies, Anti-Idiotypic; B-Lymphocytes; Chloroquine; Furans; Immunoglobulin G; Kinetics; Lymphocyte Activation; Monensin; Puromycin; Rabbits | 1983 |
In vitro effects of various metabolic inhibitors on the formation of inactive renin and the loss of renin in rabbit uterine tissue.
Topics: Animals; Chloroquine; Dinitrophenols; Energy Metabolism; Female; Glucose; Iodoacetates; Kidney Cortex; Lysosomes; Pregnancy; Puromycin; Rabbits; Renin; Uterus | 1981 |
Inhibition of hepatocytic protein degradation by inducers of autophagosome accumulation.
Topics: Animals; Autophagy; Cadmium; Chloroquine; Colchicine; Liver; Male; Neutral Red; Octoxynol; Phagocytosis; Polyethylene Glycols; Proteins; Puromycin; Rats; Rats, Inbred Strains; Sucrose; Vinblastine | 1982 |
Mechanisms of protein degradation in Trypanosoma cruzi.
Topics: Animals; Chloroquine; Cysteine Endopeptidases; Hydrogen-Ion Concentration; Intracellular Membranes; Leucine; Molecular Weight; Peptide Hydrolases; Protease Inhibitors; Protozoan Proteins; Puromycin; Time Factors; Trypanosoma cruzi; Ubiquitins | 1993 |
Inhibition of autophagy of fetal rabbit gonoducts by puromycin, tunicamycin and chloroquin in organ culture.
Topics: Animals; Autophagy; Biological Transport; Chloroquine; Enzyme Activation; Female; Male; Mullerian Ducts; Organ Culture Techniques; Puromycin; Rabbits; Tunicamycin; Wolffian Ducts | 1996 |
Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association.
Topics: Anti-Bacterial Agents; Antigen Presentation; Antimalarials; Brefeldin A; CD4 Antigens; CD8 Antigens; Cell Adhesion Molecules, Neuronal; Cell Line; Cell Separation; Chloroquine; Cytoplasm; Cytosol; Endoplasmic Reticulum; Epitopes; Flow Cytometry; Glycoproteins; Golgi Apparatus; GPI-Linked Proteins; HeLa Cells; Hexosaminidases; Histocompatibility Antigens Class I; Humans; Immediate-Early Proteins; Lysosomes; Macrolides; Membrane Proteins; Microscopy, Confocal; Precipitin Tests; Protein Transport; Puromycin; Time Factors; Transfection | 2000 |
Relationship of chloroquine-induced redistribution of a neutral aminopeptidase to hemoglobin accumulation in malaria parasites.
Topics: Aminopeptidases; Anilides; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Endocytosis; Erythrocyte Membrane; Erythrocytes; Hemin; Hemoglobins; Hydrogen-Ion Concentration; Malaria; Male; Mice; Microscopy, Electron; Plasmodium berghei; Puromycin; Temperature; Time Factors; Trypanocidal Agents | 2003 |
Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors.
Topics: Activating Transcription Factor 4; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Chloroquine; Cinnamates; Endoplasmic Reticulum Chaperone BiP; Eukaryotic Initiation Factor-2; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lysosomes; Mifepristone; Ovarian Neoplasms; Platinum; Proteasome Inhibitors; Protein Biosynthesis; Puromycin; RNA, Messenger; Signal Transduction; Thiourea; Tunicamycin; Unfolded Protein Response | 2016 |